Viome Life Sciences has announced a collaboration with Microsoft to advance preventive and personalized healthcare through AI and RNA-based diagnostics. Viome will integrate its extensive dataset of human and microbial gene expression with Microsoft Azure’s secure and scalable infrastructure services, including Ultra Disk Storage and Virtual Machines. Naveen Jain, Founder and CEO of Viome, stated, “We're excited to partner with Microsoft to create a biological digital twin for every individual, helping us make illness optional.” The company’s Full Body Intelligence Test analyzes saliva, blood, and stool samples to assess molecular activity and offer tailored health recommendations.
Viome’s proprietary AI models process this data to detect early signs of inflammation, immune issues, and molecular patterns linked to chronic conditions. Its solutions have demonstrated measurable results, including a 58% reduction in IBS symptoms and a 31% reduction in symptoms of depression and anxiety. Dr. Guru Banavar, Founding CTO of Viome, stated, “We're thrilled to collaborate with Microsoft to decode molecular signals at scale and transform raw biology into personalized health insights. With Microsoft, we can securely scale our existing platform to process petabyte-scale customer data and make preventive healthcare accessible to all." Microsoft’s General Manager, Worldwide Healthcare Elena Bonfiglioli highlighted, "Integrating Microsoft Azure infrastructure services with Viome's scientific leadership and innovation are helping to better support the next generation of life science pioneers." She added the collaboration helps combine AI and biology to develop effective home-based health solutions using Azure and Viome’s expert
